LLEGO Read More Review: LEGO Minifigures Series 29 (71052)2026-04-21 April 21, 2026 | 2 LEGO Minifigures Series 29 arrives on the scene on 1 May 2025 globally,…
NNovo Nordisk Read More Why Eli Lilly Is Leaving Novo Nordisk in the Dust2026-04-21 Three years ago, Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) had about the same market value.…
ØØrsted Read More Does offshore wind execution now become the real test?2026-04-21 As Ørsted advances massive offshore wind projects amid rising costs and policy shifts, you need to assess if…
NNovo Nordisk Read More Novo Nordisk’s Blood Disorder Breakthrough Offers a Lifeline Amid GLP-1 Gloom2026-04-21 Novo Nordisk’s etavopivat succeeds in Phase 3 sickle cell trial, cutting painful crises by 27%. This diversifies its…
ØØrsted Read More Is its offshore wind leadership strong enough to unlock U.S. upsid2026-04-21 Ørsted leads in offshore wind with massive projects worldwide, but execution risks loom as U.S. markets heat up.…
NNovo Nordisk Read More Lobbying Update: $1,290,000 of NOVO NORDISK INC. lobbying was just disclosed2026-04-21 $1,290,000 of NOVO NORDISK INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure…
ØØrsted Read More Is This ‘Green Energy King’ Stock a Secret Steal or Total Trap?2026-04-21 Everyone’s yelling about Ørsted and the green energy crash. Is this the comeback play of the decade or…
NNovo Nordisk Read More Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease2026-04-21 Novo Nordisk A/S Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive…
MMærsk Read More Is It Time To Reassess Maersk (CPSE:MAERSK B) After A 43% One Year Rally?2026-04-21 Wondering whether A.P. Møller – Mærsk is priced attractively right now, or if the recent run leaves less…
NNovo Nordisk Read More Novo Nordisk’s Clinical Win and Competitive Crossroads2026-04-20 Novo Nordisk’s etavopivat meets Phase 3 goals in sickle cell disease, a bright spot as shares fall 23%…
DDFDS Read More Ferry damaged after hitting berth in St Helier, Jersey2026-04-20 DFDS and Ports of Jersey have begun investigating the mishap and assessing the extent of damage sustained by…
DDFDS Read More Rosyth to Dunkirk ferry update given by French port boss2026-04-20 Danish company DFDS plans to operate three sailings a week between the two ports, but the project was…